Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maria Chiara TISI"'
Autor:
Giulia Bega, Jacopo Olivieri, Marcello Riva, Greta Scapinello, Rossella Paolini, Silvia Finotto, Roberto Sartori, Elisa Lucchini, Gianmarco Guandalini, Davide Facchinelli, Maria Chiara Tisi, Marco Basso, Laura Ballotta, Francesco Piazza, Isacco Ferrarini, Carlo Visco
Publikováno v:
Cancers, Vol 13, Iss 23, p 6089 (2021)
Background: Rituximab plus bendamustine (BR), and rituximab, bendamustine, and cytarabine (R-BAC) are well-known induction therapies in elderly patients with mantle cell lymphoma (MCL), according to clinical guidelines. However, a direct comparison b
Externí odkaz:
https://doaj.org/article/43b6dff5d0e7440588e524305d03f9aa
Autor:
Jacopo Olivieri, Davide Facchinelli, Roberto Sartori, Rossella Paolini, Marco Basso, Francesco Piazza, Carlo Visco, Greta Scapinello, Elisa Lucchini, Gianmarco Guandalini, Giulia Bega, Isacco Ferrarini, Marcello Riva, Silvia Finotto, Laura Ballotta, Maria Chiara Tisi
Publikováno v:
Cancers
Cancers, Vol 13, Iss 6089, p 6089 (2021)
Cancers; Volume 13; Issue 23; Pages: 6089
Cancers, Vol 13, Iss 6089, p 6089 (2021)
Cancers; Volume 13; Issue 23; Pages: 6089
Simple Summary Both BR, and R-BAC are suitable induction therapies in elderly patients with mantle cell lymphoma (MCL). However, the two regimens have not been compared before. We retrospectively analysed the outcome and the safety features of elderl
Autor:
Guido Gini, Piero Maria Stefani, Luca Nassi, Tommasina Perrone, Simon Rule, Monica Balzarotti, Cristina Tecchio, Valentina Bozzoli, Antonello Sica, Luca Arcaini, Alessandro Re, Carlo Visco, Annalisa Chiappella, Maria Christina Cox, Simone Ferrero, Roberta Sciarra, Maria Chiara Tisi, Mauro Krampera, Chiara Rusconi, Andrea Evangelista, Vittorio Ruggero Zilioli, Maria Isabel Alvarez De Celis, Alice Di Rocco, Elsa Pennese, Ana Marin-Niebla, Rory McCulloch, Alberto Fabbri, Umberto Vitolo, Lucia Morello, Francesca Maria Quaglia, Stefan Hohaus, Valentina Polli, Luca Petrucci
Patients with mantle cell lymphoma (MCL) that fail induction treatment represent a difficult-to-treat population, where no standard therapy exists. We evaluated outcomes in patients with first relapsed-refractory (r/r) MCL after upfront high dose cyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cb9271c7ec247f0468782f0ca4b6036
http://hdl.handle.net/2318/1791410
http://hdl.handle.net/2318/1791410
Autor:
Cristina Tecchio, Lucia Morello, Carlo Visco, Chiara De Philippis, Roberta Sciarra, Maria Chiara Tisi, Maria Isabel Alvarez De Celis, Luca Nassi, Irene Dogliotti, Alice Di Rocco, Luigi Marcheselli, Nicola Bianchetti, Annalisa Arcari, Vittorio Ruggero Zilioli, Michele Merli, Anna Lia Molinari, Guido Gini, Tommasina Perrone, Annalisa Chiappella, Valentina Bozzoli, Stefano Volpetti, Francesca Maria Quaglia, Stefan Hohaus, Matteo Pelosini, Alberto Fabbri, Daniele Vallisa
The role of allogeneic stem cell transplantation (allo-SCT) in mantle cell lymphoma (MCL) is uncertain, even more in the era of bruton's tyrosine kinase inhibitors (BTKi) and chimeric antigen receptor T-cells. We retrospectively analyzed 55 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f0e3d30712ac80055a5c9803e8e000
http://hdl.handle.net/11562/1064985
http://hdl.handle.net/11562/1064985
Autor:
Guido Gini, Claudia Castellino, Michele Spina, Armando Santoro, Francesco Merli, Roberta Sciarra, Maria Chiara Tisi, Giacomo Loseto, Vincenzo Pavone, Claudia Peracchio, Valentina Tabanelli, Alice Di Rocco, Andrés J.M. Ferreri, Michele Merli, Sara Veronica Usai, Pietro Maria Stefani, Federica Cavallo, Stefano Pileri, Stefano Fiori, Annalisa Arcari, Carlo Visco, Gerardo Musuraca, Benedetta Puccini, Monica Balzarotti, Monica Tani, Caterina Patti, Caterina Stelitano, Paolo Corradini, Alessandro Re, Vittorio Ruggero Zilioli, Costanza Fraenza, Andrea Evangelista, Stefano Volpetti, Carola Boccomini, Pier Luigi Zinzani, Stefan Hohaus, Filippo Ballerini, Anna Merli, Francesco Piazza, Valeria Ferla, Riccardo Bruna, M. Ladetto
Publikováno v:
Blood. 138:2427-2427
The R-BAC regimen is considered among standard first-line treatment for elderly fit patients with mantle cell lymphoma (MCL). In the previous R-BAC500 FIL trial, patients with the blastoid variant and/or high Ki67 proliferative index (High Risk - HR-
Autor:
Manuela Zanni, Monica Tani, Luca Nassi, Simone Ferrero, Martina Ferrante, Emanuele Cencini, Chiara Ghiggi, Carlo Visco, Caterina Patti, Claudio Chini, Michele Spina, Benedetta Puccini, Stefano Volpetti, Renato Zambello, Alessandro Re, Vittorio Ruggero Zilioli, Barbara Botto, Roberta Sciarra, Maria Chiara Tisi, Annalisa Arcari, Anna Lia Molinari, Caterina Stelitano, Alice Di Rocco, Francesco Merli
Publikováno v:
Blood. 138:384-384
The activity of the combination of rituximab, bendamustine, and low dose cytarabine (R-BAC) was evaluated in a phase 2 multicentre trial from the Fondazione Italiana Linfomi (FIL RBAC500) in previously untreated patients with mantle cell lymphoma (MC
Autor:
Benedetta Puccini, Marco Ruggeri, Eva Hoster, Roberta Sciarra, Maria Chiara Tisi, Simone Ferrero, Michele Merli, Umberto Vitolo, Alice Di Rocco, Luca Nassi, Vittorio Ruggero Zilioli, Guido Gini, Cristina Tecchio, Erica Finolezzi, Isabel Alvarez De Celis, Lucia Morello, Andrea Evangelista, Alessandro Re, Dario Marino, Tommasina Perrone, Carlo Visco, Alberto Fabbri, Martin Dreyling, Massimo Gentile, Olivier Hermine, Stefan Hohaus, Fondazione Italiana Linfomi, Anna Lia Molinari, Annalisa Arcari, Annalisa Chiappella, Francesco Piazza, Giacomo Loseto, Matteo Pelosini, Maria Christina Cox, Maurizio Martelli, Anna-Katharina Zoellner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83dd9c7b6f18de112c32ec7943875cca
http://hdl.handle.net/10807/141173
http://hdl.handle.net/10807/141173
Autor:
Guido Gini, Valentina Polli, Tommasina Perrone, Piero Maria Stefani, Simone Ferrero, Luca Nassi, Luca Petrucci, Chiara Rusconi, Vittorio Ruggero Zilioli, Luca Arcaini, Cristina Tecchio, Simon Rule, Monica Balzarotti, Alessandro Re, Mauro Krampera, Umberto Vitolo, Francesca Maria Quaglia, Stefan Hohaus, Antonello Sica, Lucia Morello, Carlo Visco, Valentina Bozzoli, Roberta Sciarra, Maria Chiara Tisi, Elsa Pennese, Alice Di Rocco, Maria Isabel Alvarez De Celis, Andrea Evangelista, Ana Marin-Niebla, Rory McCulloch, Alberto Fabbri, Annalisa Chiappella, Maria Christina Cox
Publikováno v:
Leukemia. 35:932-932